| Literature DB >> 8280492 |
L T Vlasveld1, J H Beijnen, J J Sein, E M Rankin, C J Melief, A Hekman.
Abstract
In a previous clinical study using a continuous infusion schedule of recombinant interleukin-2 (rIL-2) we noted a nearly complete loss of activity of EuroCetus rIL-2 when dissolved in 10 ml saline and infused at a very low rate through a plastic infusion device. In the present study, we demonstrated that the loss resulted from a concentration-dependent precipitation of rIL-2 in saline and adherence of the protein to the tubing material. These phenomena were not noted for four other rIL-2 muteins tested [Glaxo, Hoffmann-LaRoche, Amgen (2 muteins)]. EuroCetus rIL-2 was found to be completely soluble in water and 5% glucose.Entities:
Mesh：
Substances：
Year: 1993 PMID： 8280492 DOI： 10.1016/0959-8049(93)90456-p
Source DB: PubMed Journal: Eur J Cancer ISSN： 0959-8049 Impact factor: 9.162